Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen(Yale Cancer Center), Xue Han(Shanxi Medical University)
Cited by 1,425
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
|Immunity|2003|694
Immunostimulatory monoclonal antibodies for cancer therapy
|Nature reviews. Cancer|2007|628